Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    Miranda A. Farage, Kenneth W. Miller, Nancy Fugate Woods, Howard I. Maibach, editors.
    Summary: An era of global population aging is upon us. By 2030, one in eight people will be over age 65. Since women generally live longer than men, the health and welfare of postmenopausal women will become a significant public health concern. This book offers a comprehensive review of the life changes associated with menopause, both at the dermatological and physiological level (e.g., hormonal, immunological) and at the subcellular level. It critically examines the dermatological, biological, and clinical challenges to postmenopausal health and well-being and the current and emerging therapeutic interventions. The authors advocate a holistic approach, emphasizing the need to view the menopause as a life transition with various facets rather than as a series of distinct medical conditions to be managed. Our goal is to offer a comprehensive resource to the researchers, clinicians, physicians, and helping professions whose mission is to promote the health and well-being of women around the world.

    Contents:
    What is Menopause?
    Skin and Menopause
    Effect of Supplementations and Vitamins on Menopause
    Hormonal Change and Therapy
    Menopause and Genital
    Menopause and Autoimmune Disease
    Hotflahes
    Other Therapy for Menopause
    Sexual Decline
    Menopause Tests
    Menopause and Sleep
    Menopause and Mental Effects
    Menopause and Quality of Life
    Menopause and cosmetic procedures.
    Digital Access Springer 2015
  • Article
    Howard MA, Whitworth JA, Hendrix LE, Thomas KB, Firkin BG.
    Med J Aust. 1979 Mar 10;1(5):148-51.
    Factor VIII procoagulant activity (VIII-C), related antigen (VIII-AG), and von Willebrand factor (VIII-vWf) were measured in 38 patients with chronic renal failure (CRF), in 19 patients with normal renal function from a general medical ward, and in 17 normal subjects. Wide variation in the levels of factor VIII (FVIII) functions were found in the group of CRF patients. There was no correlation between the levels of the three individual activities of FVIII in renal disease. The levels of the three functions were elevated in the patient controls and no significant differences were found between the two groups of patients, although both groups were significantly different from the normal subjects. Increased electrophoretic mobility (EM) was detected in 22 of the 38 patients with CRF (58%) compared to seven of the 19 patients controls (37%). These studies suggest caution in interpretation of changes in FVIII status in patients with other clinical disorders, such as liver disease.
    Digital Access Access Options